Dynamic Hormone Diagnostics in Endocrine Disease

CompletedOBSERVATIONAL
Enrollment

528

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

November 14, 2023

Study Completion Date

November 14, 2023

Conditions
Adrenal InsufficiencyCongenital Adrenal HyperplasiaCushing SyndromeGrowth Hormone DeficiencyAcromegalyPrimary Hyperaldosteronism
Interventions
OTHER

27 hour subcutaneous fluid sampling

"One hour prior to the microdialysis catheter insertion the participants will be asked to receive a local anaesthetic on the injection site for the microdialysis catheter. Lignocaine 1% will be injected subcutaneously at a localised site on the abdomen covering a horizontal area of about 5cm after a brief acclimatisation period at the hospital.~A sterile linear catheter will be inserted using aseptic precautions at the anaesthetised site on the abdomen. The catheter is connected at one end to the microdialysis pump, and at the other end to the automated collection device. Subcutaneous tissue microdialysis samples will be collected regularly for the duration of the sampling period (27 hours)."

Trial Locations (4)

Unknown

Evangelissmos hospital, Athens

Haukeland University Hospital, Bergen

Karolinska Institutet, Stockholm

Bristol University hospital, Bristol

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

collaborator

University Hospitals Bristol and Weston NHS Foundation Trust

OTHER

collaborator

Evaggelismos Hospital, Greece

UNKNOWN

lead

Haukeland University Hospital

OTHER

NCT02934399 - Dynamic Hormone Diagnostics in Endocrine Disease | Biotech Hunter | Biotech Hunter